Screener
Aquestive Therapeutics, Inc. AQST Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000030
FAQ
- What is Aquestive Therapeutics, Inc.'s operating margin?
- Aquestive Therapeutics, Inc. (AQST) reported operating margin of -111.2% in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s operating margin changed year-over-year?
- Aquestive Therapeutics, Inc.'s operating margin decreased by 46.4% year-over-year, from -75.9% to -111.2%.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s operating margin?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s operating margin has grown at a 11.3% compound annual growth rate (CAGR), from -93.6% to -159.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Aquestive Therapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude